Pulse Biosciences annual gross margin
2021
2022
2025
Pulse Biosciences Gross Margin Growth & History (PLSE)
Pulse Biosciences's gross margin was −54.00% for fiscal 2025.
View full Pulse Biosciences company overviewPulse Biosciences annual gross margin history
| Fiscal year | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −54.00% | — |
| 2022 | 2022-12-31 | −1,606.29% | −1567.50 pp |
| 2021 | 2021-12-31 | −38.79% | — |
Pulse Biosciences quarterly gross margin
Q3.21
Q1.22
Q2.22
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | 37.10% | — |
| Q1 2026 | 2026-03-31 | 7.73% | — |
| Q4 2025 | 2025-12-31 | 1.52% | — |
| Q3 2025 | 2025-09-30 | −224.42% | — |
| Q2 2022 | 2022-06-30 | −407.17% | — |
| Q1 2022 | 2022-03-31 | −104.73% | — |
| Q3 2021 | 2021-09-30 | −26.66% | — |
Pulse Biosciences gross margin trends
Between the periods ended 2021-12-31 and 2025-12-31, Pulse Biosciences's gross margin decreased from −38.79% to −54.00%, a change of −15.21 percentage points. The latest reported quarter, Q2 2026, shows 37.10%.
About the metric
What gross margin means
Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.
Calculation and source
How gross margin is calculated
TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Pulse Biosciences source filings ↗